-
Pfizer and American Home Products will be manic and poised to lead the group, Bristol-Myers Squibb and Merck appear to be stick in the middle and Eli Lilly and Schering-Plough will be down in the dumps,
-
With Viagra you've got an onset of action of an hour and it lasts for four hours, and here's a new drug that has an onset of 16 minutes and lasts all day, ... Which might appeal for someone who wants to have more flexibility with their sexual experience.
-
The company doesn't have a financial crisis at hand and pays a handsome dividend. The question is, Does the company become more efficient selling and manufacturing its products?
-
I don't see any pressure on them to settle in the near term.
-
There's not a company that's not swept up in this wave of cost analysis,
-
I've got to look sharp. You're talking to the sheriff of this county.
-
I think that what we continue to learn is that the hurdle rate of the FDA has gotten higher,
-
I've never seen anything like that. And hopefully, nobody else will have to.
-
We believe Pfizer is more likely to either sell this consumer health business or perhaps create some type of partnership with another consumer health business where synergies could exist.
-
We're probably looking at short term, that's from now until January. But there are also emergency loans which start from one month and can be extended to three so they are a possibility as well.